Modelling human granulopoiesis under poly-chemotherapy with G-CSF support. (Q51981581)

19 April 2018

title

Modelling human granulopoiesis under poly-chemotherapy with G-CSF support. (English)

1 reference

19 April 2018

1 reference

2

C Engel

1 reference

19 April 2018

M Scholz

1

1 reference

19 April 2018

M Loeffler

series ordinal

3

1 reference

19 April 2018

publication date

20 December 2004

1 reference

19 April 2018

number of pages

43

1 reference

Journal of Mathematical Biology

inferred from page(s)

published in

1 reference

19 April 2018

volume

50

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

page(s)

397-439

1 reference

19 April 2018

maintained by WikiProject

WikiProject Mathematics

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s00285-004-0295-1

0 references

cites work

The clinical use of mutagenic anticancer drugs.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00285-004-0295-1

Etoposide: A Semisynthetic Epipodophyllotoxin Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects and Use as an Antineoplastic Agent

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00285-004-0295-1

Model analysis of the contrasting effects of GM-CSF and G-CSF treatment on peripheral blood neutrophils observed in three patients with childhood-onset cyclic neutropenia.

21 January 2018

1 reference

12 December 2020

A mathematical model of erythropoiesis in mice and rats. Part 1: Structure of the model

1 reference

12 December 2020

Theoretical basis for cell cycle analysis: II. Further studies on labelled mitosis wave method.

1 reference

12 December 2020

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

12 December 2020

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

1 reference

12 December 2020

The pharmacokinetics of [3H]-vincristine in man

1 reference

12 December 2020

Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products

1 reference

12 December 2020

The rate of apoptosis in post mitotic neutrophil precursors of normal and neutropenic humans.

1 reference

12 December 2020

Induction and regulation of endogenous granulocyte colony-stimulating factor formation

1 reference

12 December 2020

Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers.

1 reference

12 December 2020

Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers

1 reference

12 December 2020

Serum granulocyte colony-stimulating factor in patients with chronic renal failure

1 reference

12 December 2020

Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections

1 reference

12 December 2020

Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis

1 reference

12 December 2020

Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF

1 reference

12 December 2020

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

1 reference

12 December 2020

The role of polymorphonuclear neutrophils (PMNs) in clearance of granulocyte colony-stimulating factor (G-CSF) in vivo and in vitro.

1 reference

12 December 2020

Leukokinetic studies. 13. A non-steady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis

1 reference

12 December 2020

A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy

1 reference

12 December 2020

Proteolytic cleavage of granulocyte colony‐stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony‐stimulating factor receptor

1 reference

12 December 2020

Effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans

1 reference

12 December 2020

Quantification of the cell kinetic effects of G-CSF using a model of human granulopoiesis.

1 reference

12 December 2020

A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation

1 reference

12 December 2020

Effects of renal function on pharmacokinetics of recombinant human granulocyte colony-stimulating factor in lung cancer patients.

1 reference

12 December 2020

Effect of escalating doses of recombinant human granulocyte colony-stimulating factor (filgrastim) on circulating neutrophils in healthy subjects

1 reference

12 December 2020

Effects of in vivo recombinant methionyl human granulocyte colony-stimulating factor on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly adult volunteers

1 reference

12 December 2020

Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: implications for the regulation of granulopoiesis

1 reference

12 December 2020

Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation

1 reference

12 December 2020

Cytotoxic Drugs and the Granulopoietic System

1 reference

12 December 2020

Granulocyte interactions with GM-CSF and G-CSF secretion by endothelial cells and monocytes

1 reference

12 December 2020

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate- and high-grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349).

1 reference

12 December 2020

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).

1 reference

12 December 2020

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

1 reference

12 December 2020

10.1007/S00285-004-0295-1

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018